Moderna Drops 11%, ImmunityBio Slide Wakes Biotech Rout
Biotech shares retreat as Moderna slides 11% and ImmunityBio falls, with Sarepta also sinking amid a broad market rot...
Some index funds distribute fewer capital gains than others, which can reduce tax surprises and improve after-tax performance over time.
28,126 articlesBiotech shares retreat as Moderna slides 11% and ImmunityBio falls, with Sarepta also sinking amid a broad market rot...
When a rental property isn’t gaining value, the decision to hold or sell can be tough. This guide spells out a practi...
Ripple unveils a day-one Open USD partnership as XRP hovers near $1, with RLUSD clearing regulatory hurdles and insti...
Choosing between Shift4 Payments and PayPal hinges on your appetite for growth versus stability. This guide breaks do...
AscendEX ceased normal operations on July 1 as MiCA rules tightened, with withdrawal requests slowed or blocked. Zach...
As of May 2026, the U.S. tech economy hinges on institutional design that turns ideas into markets. This piece explai...
The 2026 Hedge Fund Alternative Manager Forum brought together leaders to share how AI, data, and differentiated stra...
Morgan Stanley’s MSBT ends its debut month with zero net outflows and a six-week inflow streak, underscoring growing ...
A looming energy squeeze could pressure household budgets and corporate profits. This article breaks down what shorta...
A 68-year-old retiree taps a charitable remainder trust strategy to divest a $2.4 million concentrated stock position...
From my early start to the hard lessons I learned along the way, here’s the real, practical insight about retirement ...
Three sector ETFs are beating the Nasdaq tech index in 2026, signaling a shift toward defense tech, electrification, ...